Drug recall · December 14, 2016
SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE INJECTION recall
Why: Subpotent Drug: Product has an an out of specification in iron assay analysis found during 18 month stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE INJECTION, 62.5mg elemental iron/5mL, 10 (5mL vials) per shelf pack, Rx only, Mfd: Hikma Farmaceutica (Portugal,) SA Distributed by: Westward Eatowntown NJ 07724 USA, Shelf pack NDC 0143-9570-10, Unit dose NDC 0143-9570-01
- Lots / codes
Lot #: 152032.1, Exp. Date. 2/2017
- Quantity
- 5,142 Shelf-packs
- Company
- West-Ward Pharmaceuticals Corp., Eatontown, NJ
- Distribution
- US nationwide
- Initiated
- November 17, 2016 · Voluntary: Firm initiated
- Classified
- December 8, 2016
- Reported
- December 14, 2016
- Ended
- April 19, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sodium ferric gluconate complex
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.